{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T02:12:07Z","timestamp":1778897527333,"version":"3.51.4"},"reference-count":16,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cvcasejournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["CASE"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.case.2026.01.003","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T20:34:50Z","timestamp":1774298090000},"page":"136-142","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["TUSI Valve: Echocardiographic and Pathologic Correlates of a Novel Drug-Induced Valvular Disease\u2014a Case Series"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9911-7687","authenticated-orcid":false,"given":"Juan Felipe","family":"Vasquez-Rodriguez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustavo","family":"Lemus-Barrios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Rangel-Rivera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Garnica-Sepulveda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeisson","family":"Avila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramon","family":"Medina-Mur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oscar M.","family":"Perez-Fernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Holgu\u00edn-Ria\u00f1o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Salazar-Castro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Due\u00f1as-Criado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.case.2026.01.003_bib2","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.acvd.2013.02.003","article-title":"Drug-induced valvular heart disease: an update","volume":"106","author":"Andrejak","year":"2013","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.case.2026.01.003_bib3","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.amjcard.2007.06.045","article-title":"Possible association between 3,4-methylenedioxymethamphetamine abuse and valvular heart disease","volume":"100","author":"Droogmans","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.case.2026.01.003_bib4","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1186\/s12889-024-18445-6","article-title":"The global burden and risk factors of cardiovascular diseases in adolescent and young adults, 1990\u20132019","volume":"24","author":"Tong","year":"2024","journal-title":"BMC Public Health"},{"key":"10.1016\/j.case.2026.01.003_bib5","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1080\/00952990.2023.2207716","article-title":"Tusi: a new ketamine concoction complicating the drug landscape","volume":"49","author":"Palamar","year":"2023","journal-title":"Am J Drug Alcohol Abuse"},{"key":"10.1016\/j.case.2026.01.003_bib6","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s13181-013-0295-x","article-title":"2C or not 2C: phenethylamine designer drug review","volume":"9","author":"Dean","year":"2013","journal-title":"J Med Toxicol"},{"key":"10.1016\/j.case.2026.01.003_bib7","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3389\/fphar.2018.00206","article-title":"Acute pharmacological effects of 2C-B in humans: an observational study","volume":"9","author":"Papaseit","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.case.2026.01.003_bib8","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1111\/add.70069","article-title":"Tusi use among the New York city nightclub-attending population","volume":"120","author":"Palamar","year":"2025","journal-title":"Addiction"},{"key":"10.1016\/j.case.2026.01.003_bib9","first-page":"1","article-title":"The psychedelic phenethylamine 25C-NBF, a selective 5-HT2A agonist, shows psychoplastogenic properties and rapid antidepressant effects in male rodents","author":"Nadal-Gratac\u00f3s","year":"2025","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.case.2026.01.003_bib10","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1108\/DHS-07-2022-0026","article-title":"\u00c9chele cabeza as a harm reduction project and activist movement in Colombia","volume":"23","author":"D\u00edaz Moreno","year":"2022","journal-title":"Drugs Habits Soc Policy"},{"key":"10.1016\/j.case.2026.01.003_bib11","doi-asserted-by":"crossref","first-page":"77457","DOI":"10.3389\/fcvm.2022.774573","article-title":"Serotonin-A driver of progressive heart valve disease","volume":"9","author":"Waldum","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.case.2026.01.003_bib12","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.echo.2009.05.002","article-title":"Role of serotoninergic pathways in drug-induced valvular heart disease and diagnostic features by echocardiography","volume":"22","author":"Smith","year":"2009","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.case.2026.01.003_bib13","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1124\/mol.63.6.1223","article-title":"3,4-Methylenedioxymethamphetamine (MDMA, \u201cEcstasy\u201d) induces fenfluramine-like proliferative actions on human cardiac valvular interstitial cells in vitro","volume":"63","author":"Setola","year":"2003","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.case.2026.01.003_bib14","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1177\/02698811231225609","article-title":"Microdosing psychedelics and the risk of cardiac fibrosis and valvulopathy: comparison to known cardiotoxins","volume":"38","author":"Rouaud","year":"2024","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.case.2026.01.003_bib15","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJM199708283370901","article-title":"Valvular heart disease associated with fenfluramine-phentermine","volume":"337","author":"Connolly","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.case.2026.01.003_bib16","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/j.jaccas.2020.09.010","article-title":"The thickened valve","volume":"2","author":"Narula Narula","year":"2020","journal-title":"JACC Case Rep"},{"key":"10.1016\/j.case.2026.01.003_bib17","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.phrs.2018.09.009","article-title":"Serotonin contribution to cardiac valve degeneration: new insights for novel therapies?","volume":"140","author":"Ayme-Dietrich","year":"2019","journal-title":"Pharmacol Res"}],"container-title":["CASE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468644126000307?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468644126000307?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T01:36:43Z","timestamp":1778895403000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468644126000307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S2468644126000307"],"URL":"https:\/\/doi.org\/10.1016\/j.case.2026.01.003","relation":{},"ISSN":["2468-6441"],"issn-type":[{"value":"2468-6441","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TUSI Valve: Echocardiographic and Pathologic Correlates of a Novel Drug-Induced Valvular Disease\u2014a Case Series","name":"articletitle","label":"Article Title"},{"value":"CASE","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.case.2026.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"2026 The Authors. Published by Elsevier Inc. on behalf of the American Society of Echocardiography.","name":"copyright","label":"Copyright"}]}}